#Closed System Drug Transfer Device Market Demand | Explore Tumblr posts and blogs

credenceresearchdotblog · 2 months ago

Text

The Vial Adaptors for Reconstitution Drug Market is experiencing robust growth, underscored by significant financial metrics and projections. As of 2023, the market is valued at USD 2,186.69 million. This dynamic sector is anticipated to reach a market size of USD 4,146.27 million by 2032, driven by a compound annual growth rate (CAGR) of 7.24% over the forecast period from 2024 to 2032. The global vial adaptors for reconstitution drug market has witnessed significant growth over the past few years, driven by the rising demand for advanced drug delivery systems, increasing prevalence of chronic diseases, and the growing need for efficient and safe drug administration methods. Vial adaptors are critical components in the pharmaceutical industry, facilitating the transfer of drugs from vials to syringes without compromising sterility. They play a crucial role in the reconstitution of lyophilized drugs, which are widely used in various therapeutic areas, including oncology, infectious diseases, and autoimmune disorders.

Browse the full report at https://www.credenceresearch.com/report/vial-adaptors-for-reconstitution-drug-market

Market Overview

The vial adaptors for reconstitution drug market is characterized by the presence of several key players, including global pharmaceutical and medical device companies. The market is segmented based on type, application, end-user, and region. The types of vial adaptors include multi-use and single-use adaptors, with single-use adaptors dominating the market due to their cost-effectiveness and reduced risk of cross-contamination. Applications of vial adaptors span across hospital pharmacies, retail pharmacies, and homecare settings, with hospital pharmacies holding a significant share of the market due to the high volume of drug administration in these settings.

Drivers of Market Growth

1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has led to an increased demand for injectable drugs, many of which require reconstitution before administration. Vial adaptors provide a safe and efficient way to reconstitute these drugs, thereby driving the growth of the market.

2. Technological Advancements: Innovations in vial adaptor design, such as the development of needle-free systems, have enhanced the safety and ease of drug reconstitution. These advancements reduce the risk of needlestick injuries and improve the overall user experience, contributing to the market's expansion.

3. Growing Geriatric Population: The global aging population is another significant factor fueling the demand for vial adaptors. Older adults are more likely to suffer from chronic conditions that require regular medication, often in injectable form. Vial adaptors simplify the process of drug reconstitution and administration, making them an essential tool in managing the health of the elderly.

4. Rising Awareness of Infection Control: In the wake of the COVID-19 pandemic, there has been an increased emphasis on infection control in healthcare settings. Vial adaptors help minimize the risk of contamination during drug reconstitution, making them a preferred choice among healthcare providers.

Regional Insights

The global vial adaptors for reconstitution drug market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the market, driven by a well-established healthcare infrastructure, high healthcare expenditure, and the presence of major pharmaceutical companies. Europe follows closely, with significant contributions from countries like Germany, the UK, and France.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. This growth is attributed to increasing healthcare investments, rising awareness about advanced drug delivery systems, and the growing burden of chronic diseases in countries such as China and India. The expanding pharmaceutical industry in these regions also contributes to the market's growth.

Challenges and Restraints

Despite the positive growth trajectory, the vial adaptors for reconstitution drug market faces several challenges. One of the primary challenges is the high cost associated with advanced vial adaptors, which may limit their adoption, particularly in developing regions. Additionally, the availability of alternative drug delivery methods, such as pre-filled syringes, could pose a threat to the market's growth.

Another challenge is the stringent regulatory environment governing the approval of medical devices and drug delivery systems. Manufacturers must comply with various regulatory requirements, which can be time-consuming and costly.

Future Prospects

The future of the vial adaptors for reconstitution drug market looks promising, with continued advancements in technology and increasing demand for safe and efficient drug administration methods. Companies are likely to focus on developing cost-effective, user-friendly, and environmentally sustainable adaptors to meet the evolving needs of healthcare providers and patients.

Furthermore, the market is expected to benefit from the growing trend of home-based healthcare, where patients require easy-to-use devices for self-administration of medications. This trend is particularly relevant in the context of chronic disease management, where long-term treatment is often necessary.

Key players

Braun Melsungen AG

Becton, Dickinson and Company

Baxter International

Miltenyi Biotec

West Pharmaceutical Services Inc.

Hanna Equipments (India) Pvt. Ltd.

Helapet Ltd

MedXL Inc.

Yukon Medical

Vygon SA

Parasol Medical, LLC

Stevanato Group

Segments

Based on Type

20 mm Vial Adaptor

Others

Based on Therapeutic Area

Infectious Diseases

Autoimmune Diseases

Metabolic Conditions

Reproductive Health

Others

Based on End User

Hospitals

Clinics

Others

Based on Material

Polycarbonate

Silicon

PET Glycol

Polyethylene

Others

Based on Delivery Mode

Injection

Infusion

Others

Browse the full report at https://www.credenceresearch.com/report/vial-adaptors-for-reconstitution-drug-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

trendingreportz · 3 months ago

Text

Bioreactors Market - Forecast(2024 - 2030)

Bioreactors Market Overview

Bioreactors Market size is estimated to reach 2.1Bn, growing at a CAGR of 6.91% during the forecast period 2020-2025. Bioreactors are devices used to develop biological processes by closely monitoring controlled environment. It is a closed system used for bioprocessing, that supports the growth of cells or tissues and organisms (yeast, bacteria, or animal cells) under controlled conditions. Bioreactors are used in industrial processes to produce vaccines, antibodies and others. It converts raw materials into useful byproducts in the bioconversion of corn into ethanol. These are commonly cylindrical, ranging in size from liters to cubic meters, and are often made of stainless steel. Single-use material is widely used in the field of mammalian cell culture and is now rapidly replacing conventional bioreactors owing towards increase the quality of the end product by reducing automation complexity.

Report Coverage

The report: “Bioreactors Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Bioreactors Market.

By Type: Continuous Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fluidized Bed Bioreactors, Packed Bed Bioreactors and Photo-Bioreactors.

By Control Type: Manual Control and Automated Control.

By Application: Lab-Scale Production, Pilot-Scale Production and Full-Scale Production.

By Material: Glass, Stainless Steel and Single-Use Plastic Polymer.

By End User: Research & Development, Biopharmaceutics and Others.

By Geography: North America, Europe, Asia-Pacific and Rest of the World.

Request Sample

Key Takeaways

The increase in the number of personalized medicines coupled with rising number of FDA approved orphan drugs has increased bio production, accelerating the bioreactors demand over the forecast years.

Rising chronic diseases and favorable government initiatives to improve healthcare infrastructure is likely to be the major driving factor for the market’s growth.

Asia-Pacific region is projected to record the fastest growth rate during the forecast period 2020-2025

By Type - Segment Analysis

In 2019, Continuous Stirred Tank Bioreactors segment dominated the Bioreactors Market in terms of revenue is estimated to grow at a CAGR of 5.91% owing towards rising production of monoclonal antibodies (MAb) therapeutics and other biological using animal cell cultures. The continuous stirred-tank reactors are the equipped with an impeller for homogenizing culture media and a sparger for delivering oxygen to the cells. It has increased surface area for oxygen transfer, so there is an increased yield of products. These are mostly used in processing of industries, in homogeneous liquid-phase flow reactions, where constant agitation is required and which further is used in pharmaceutical industries abetting towards the growth of the market.

Inquiry Before Buying

Geography - Segment Analysis

In 2019, the North America region dominated Bioreactors Market in terms of revenue with a market share of 41.8% owing towards rising public & private funding for R&D in this region. In U.S., National Institute of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers with total investment of $215m aids to the market’s growth. Government has taken initiatives to promote technological advancements and initiatives to escalate the drug development process are key factors in the growth of the Bioreactors market. Asia Pacific is set to record the fastest growth rate during the forecast period 2020-2025.

Schedule a Call

Drivers – Bioreactors Market

Rapid Growth Of Single Use Bioreactors In Biopharmaceutical Industries

The increasing adoption of single use bioreactors by biopharmaceutical companies and various research institutions is driving the growth of the market. Single use bioreactors are more feasible than traditional bioreactors for small-scale research and lab-scale applications as they are more economical and flexible. The use of SUBs for the production of biopharmaceutical companies are increasing, as it tends to be more cost-effective for small-scale operations are driving the markets growth.

Challenges – Bioreactors Market

Major Regulatory Concerns

Regulatory concerns regarding usage of bioreactors and growing stringent government policy and regulation toward market growth is restraining growth of the market. Lack of sufficient storage facilities, vulnerability to leaching and transportation is hindering the market’s growth. Also, large-scale disposal of plastic derivatives is a growing environmental concern restraining the business growth over the forecast years.

Buy Now

Bioreactors Industry Outlook

Product Launches was the key strategy of the players in the Bioreactors Industry. Bioreactors top 10 companies include Danaher Corporation, Sartorius AG, Eppendorf AG, ZETA Holding GmbH, Applikon Biotechnology B.V., Solaris Biotechnology srl, Pierre Guerin Technologies, Thermo Fisher Scientific Inc., Finesse Solutions, Inc. and Merck KGaA.

Acquisitions/Product Launches

In May 2019, Sartorius AG, a leading international partner of the biopharmaceutical industry launched ambr® 15 cell culture automated microbioreactor system. It offers increased flexibility and expanded capability for clone selection, media and feed optimization and early process development work.

In March 2020, Thermo Fisher Scientific Inc. to acquire QIAGEN, a leading provider of life science and molecular diagnostic solutions. This acquisition provided opportunity to leverage the industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs.

In March 2020, Danaher Corporation acquired Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. This acquisition helped company by driving its growth across multiple categories and in reaching more consumers.

#Bioreactors Market #Bioreactors Market Share #Bioreactors Market Size #Bioreactors Market Forecast #Bioreactors Market Report #Bioreactors Market Growth

0 notes

pranalip · 3 months ago

Text

Closed System Transfer Devices Market Detailed Analysis And Forecast 2024-2033 | Global Insight Services

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global closed system transfer devices market was valued at USD 914.0 Million in 2021 and it is anticipated to grow at 18.1% CAGR during the forecast period to reach up to USD 4834.1 Million by 2031.

A closed system transfer device or “CSTD” is a drug transfer device, which mechanically restricts the transfer of environmental contamination in the medical system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway. CSTDs work by preventing- uncontrolled inflow and outflow of contaminants and drugs, preserving the quality of the solution to be infused into a patient. These devices ensure the safety of healthcare workers during the usage of hazardous drugs or chemicals. Closed system transfer device designs and models have changed at a rapid rate in recent years, resulting in the development of a number of independent testing methodologies to assess closed system transfer device performance. Currently, manufacturers in the closed system transfer devices market are focusing more on adhering to performance requirements, which largely focus on patient safety and sterile practices.

View The Full Report Here –https://www.globalinsightservices.com/reports/closed-system-transfer-devices-market

Market Trends and Drivers

The key factors such as rising use of CSTDs to combat the harmful effect of cytotoxic and antineoplastic drugs. Antineoplastic drugs are widely used in the treatment of cancer and are considered hazardous drugs. Healthcare workers involved in the preparation, transport, distribution, administration (pre and post-administration), and disposal of these drugs are at extremely high risk. The National Institute for Occupational Safety and Health (NIOSH) recommends the use of CSTDs to eliminate the harmful effects caused by exposure to hazardous substances that escape out of the system during drug preparation and administration. CSTDs act as a barrier and prevents the entry of contaminants prevent the transfer of contaminants from the atmosphere to a sterile environment. Due to these advantages, CSTDs are increasingly being used in healthcare facilities to combat the harmful effects of hazardous drugs.

Chemotherapy, a widely adopted cancer treatment, uses one or more antineoplastic drugs, which destroy abnormal cells in patients. The use of closed system transfer devices (CSTDs) in conjunction with other safety precautions such as gloves, gowns, masks, and vented preparation hoods is an effective way to increase safety when preparing, transporting, administering, and disposing of hazardous drugs. With the increasing incidence of cancer and increasing adoption of chemotherapy treatments, the demand for CSTDs is expected to increase in the upcoming years.

Market Restraints and Challenges

The major factor hindering the market growth is the high cost of implementation of CSTDs and lack of reimbursement. The cost of a closed system transfer device is one of the major constraints limiting its adoption in healthcare facilities. The cost of a typical CSTD primarily depends upon factors like manufacturer, components used, and drug that is to be administered. Moreover, since CSTDs are meant for single-use, the cost per unit is higher than regular syringes. The median price of CSTD ranges between USD8-12 per dose. According to the regulatory guidelines, CSTDs are categorized as IV consumables. Its usage is not mandatory in European and other developing nations. Since the use of these devices is absolutely voluntary in these countries, its reimbursement is unlikely. Hence, the lack of standard guidelines further acts as a hindrance to the adoption of these devices.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10257

Market Segments

By Closing Mechanism

Push to Lock System

Click to Lock System

Luer Lock System

Color to Color Alignment System

By Type

Membrane to Membrane Systems

Needleless Systems

By Component

Vial Access Devices

Syringe Safety Devices

Bag/Line Access Devices

Accessories

By End User

Hospitals & Clinics

Oncology Centers

Others

Major Players in Closed System Transfer Devices Market

The key players in the closed system transfer devices market are B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd, Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd. (JMS Co Ltd.), Yukon Medical.

COVID-19 Impact

The outbreak of COVID-19 led to a decrease in the demand for CSTDs during the first two quarters of 2020. Due to the virus containment norms and nationwide lockdowns, there were limited patient footfalls in hospitals, mostly related to COVID-19 and emergency cases. The elective medical procedures are on hold thereby causing a negative shift in the demand for CSTDs. Still, with the decline in the number of active COVID-19 cases coupled with the economic recovery in developed nations, further utilization of these devices may be expected in the near future.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10257

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: [email protected] Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

0 notes

poonamcmi · 4 months ago

Text

Closed System Transfer Device Market Set for Robust Growth due to Growing Adoption of Safety

Closed system transfer devices are used for compounding and administering hazardous drugs as well as transferring liquids between two separated vessels during manufacturing and packaging processes. CSTDs help prevent occupational exposure to hazardous drugs and allow for drug handling in a closed environment, thereby minimizing potential exposure. Growing safety concerns regarding hazardous drugs in the healthcare industry have boosted the demand for closed system transfer devices.

The closed system transfer device market is estimated to be valued at USD 1.40 Bn in 2024 and is expected to reach USD 4.07 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2024 to 2031.

Key Takeaways

Key players operating in the closed system transfer device market are General Electric, Molded Fiber Glass, Vesta, AREVA WIND, Bora Energy AVANTIS Energy, DeWind, ENERCON, EWT, GBT Composites Technology, Xinjiang Goldwind Science and Technology, Hexcel, Indutch composites technology, Inoxwind, Reliance Industries, Leitner, NORDEX, ReGen Powertech, SR Fibreglass Auto, and Wind World.

The growing geriatric population and increasing incidence of chronic diseases are fueling the demand for pharmaceutical drugs. This has resulted in significant opportunities for closed system transfer device manufacturers to strengthen their market position through new product launches that meet stringent safety standards.

North America dominates the Closed System Transfer Device Market Demand owing to stringent regulatory policies regarding drug safety in the region. However, Asia Pacific is expected to offer lucrative growth opportunities during the forecast period with the growing pharmaceutical industry in India and China and increasing healthcare expenditures. Market players are expanding their manufacturing facilities and distribution networks in emerging regions to capitalize on high growth opportunities.

Market Drivers

Stringent regulations regarding occupational safety in healthcare institutions handling cytotoxic drugs is a major factor driving the adoption of closed system transfer devices. For instance, NIOSH recommends the use of CSTDs for compounding, preparing, and administering hazardous drugs. The device allows for drug transfer while minimizing the release of toxic drug vapors. Growing awareness about the health hazards of occupational exposure to cytotoxic drugs among healthcare workers is further propelling the need for closed drug transfer systems.

PEST Analysis Political: The healthcare regulatory policies and approval procedures by various government bodies impacts the adoption of closed system transfer device systems in different regions.

Economic: Factors such as growing healthcare expenditures, rising focus on safety of healthcare workers from biohazard exposure, and availability of funding from private and public sources influence the demand for closed system transfer devices.

Social: Increasing patient awareness regarding safety, growing focus on error proofing healthcare delivery systems, and technological advancements drive the preference for Closed System Transfer Device market Size And Trends over traditional devices.

Technological: Advancements in material sciences, automation, and integration of smart sensors are enabling the development of advanced closed system transfer devices with improved functionalities and safety features. Continuous technological upgrading remains important.

Geographical Regions

North America accounts for the largest share of the closed system transfer device market in terms of value, led by the extensive adoption across healthcare facilities and stringent worker safety regulations in the US and Canada.

Asia Pacific is poised to be the fastest growing regional market for closed system transfer devices during the forecast period, driven by factors such as the rising health expenditure, increasing patient pool, growingMedical tourism industry, and strengthening regulatory standards regarding hazardous drug handling across major countries. Regions where market is concentrated and fastest growing region:

The market for closed system transfer device is concentrated in North America region in terms of value due to extensive adoption across healthcare facilities and stringent worker safety regulations in US and Canada. Asia Pacific region is poised to be the fastest growing region during the forecast period due to factors like rising health expenditure, increasing patient pool, growing medical tourism industry and strengthening regulatory standards regarding hazardous drug handling across major countries. Get More Insights On, Closed System Transfer Device Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

#Demand #Closed System Transfer Device Market Size #Closed System Transfer Device Market Trends #Closed System Transfer Device #Closed System Transfer Device Market

0 notes

pranalipawarshinde · 4 months ago

Text

Closed System Transfer Devices Market – Latest Trends Analysis And Forecast 2024-2033

View The Full Report Here –https://www.globalinsightservices.com/reports/closed-system-transfer-devices-market

Market Trends and Drivers

Market Restraints and Challenges

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10257

Market Segments

By Closing Mechanism

Push to Lock System

Click to Lock System

Luer Lock System

Color to Color Alignment System

By Type

Membrane to Membrane Systems

Needleless Systems

By Component

Vial Access Devices

Syringe Safety Devices

Bag/Line Access Devices

Accessories

By End User

Hospitals & Clinics

Oncology Centers

Others

Major Players in Closed System Transfer Devices Market

COVID-19 Impact

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10257

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: [email protected] Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

#Closed System Transfer Devices Market #Closed System Transfer Devices Market Forecast #Closed System Transfer Devices Market Analysis #Closed System Transfer Devices Market Demand #Closed System Transfer Devices Market Growth

0 notes

alicesara611 · 1 year ago

Text

The Impact of Technological Advancements on the Closed System Drug Transfer Device Market By 2023 to 2030

The global closed system drug transfer device (CSTD) market is expected to grow from US$ 1519.51 million in 2023 to US$ 5206.9 million by 2030, at a CAGR of 22.79%. Closed System Drug Transfer Devices (CSTDs) are medical devices that are used to transfer hazardous drugs from one container to another without exposing healthcare workers to the drug or its aerosolized particles. CSTDs are becoming increasingly popular, as they can help to reduce the risk of occupational exposure to hazardous drugs, which can lead to a number of health problems, including cancer, reproductive problems, and respiratory problems.

The closed system drug-transfer device, or closed system transfer device (CSTD), is a widely used device that stops dangerous environmental toxins from entering the system. Additionally, it limits the amount of dangerous drug vapor concentrations that can exit the system. Currently, there are two basic design approaches used in closed system transfer devices: one that incorporates physical barriers and another that uses air-cleaning technologies. The closed system transfer devices (CSTD) market is anticipated to grow during the forecast period as a result of the growing emphasis on enhancing the general safety of healthcare personnel who are in charge of administering and synthesizing hazardous medications.

Request A Report Sample To Gain Comprehensive Insights! https://bit.ly/3sfUMY9

Closed system drug transfer devices (CSTDs) are medical devices that protect healthcare workers and patients from exposure to hazardous drugs. CSTDs create a closed system during the preparation, administration, and disposal of hazardous drugs, minimizing the risk of drug aerosols, drug contamination, sharps exposure, and hazardous drug exposure.

Key Takeaways:

The global closed system drug transfer device (CSTD) market is expected to grow from US$ 1519.51 million in 2023 to US$ 5206.9 million by 2030, at a CAGR of 22.79%.

The growth of the market is attributed to the increasing use of CSTDs to reduce the risk of exposure to hazardous drugs and other hazardous substances, as well as the rising prevalence of cancer and other chronic diseases.

The oncology segment is expected to account for the largest share of the market during the forecast period, due to the increasing use of CSTDs for the administration of chemotherapy drugs.

The North American region is expected to dominate the market during the forecast period, owing to the early adoption of CSTDs in the region and the presence of a large number of key players.

Regional Outlook:

The global CSTD market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is expected to remain the largest market for CSTDs during the forecast period, owing to the early adoption of CSTDs in the region and the presence of a large number of key players.

Europe is expected to be the second-largest market for CSTDs during the forecast period, due to the increasing awareness of the benefits of CSTDs and the rising prevalence of chronic diseases in the region.

The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the increasing prevalence of cancer and other chronic diseases, as well as the rising demand for CSTDs in emerging economies such as India and China.

Key Players:

The key players in the global CSTD market include:

BD Medical, Inc.

ICU Medical, Inc.

Equashield, LLC

Hospira

Chemolock

B. Braun Medical Inc.

Teva Medical Ltd.

Corvida Medical

OnGuard

Baxter International Inc.

Medline Industries, Inc.

Segmentation:

The global CSTD market is segmented based on type, application, and end user.

By Type:

Closed vial transfer devices

Closed syringe transfer devices

Closed IV admixtures transfer devices

Others

By Application:

Oncology

Non-oncology

By End User:

Hospitals

Ambulatory surgical centers

Home healthcare

Others

#Closed System Drug Transfer Device (CSTD) Market

0 notes

vanshika393 · 1 year ago

Text

Closed System Transfer Devices Market- Share and Demand Analysis with Size, Growth Drivers and Forecast to 2030 | Credence Research

The latest market report published by Credence Research, Inc. “Global Closed System Transfer Devices Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030. The global Closed System Transfer Devices Market has been steadily growing in recent years and is predicted to grow at a 20.30% CAGR between 2023 and 2030. The market is anticipated to be worth USD 4934.0 million by 2030, up from USD 1124.8 million in 2022.

The Closed System Transfer Devices (CSTD) Market refers to the industry involved in the development, manufacturing, and distribution of specialized medical devices designed to safely transfer and handle hazardous drugs in healthcare settings. These devices are primarily used to protect healthcare workers, patients, and the environment from exposure to potentially harmful drugs, such as chemotherapy medications and other toxic substances.

Closed System Transfer Devices consist of various components, including vials, syringes, connectors, and tubing systems, all of which are designed to create a closed and sealed system for drug transfer. This closed system minimizes the risk of drug spills, aerosolization, and contamination during the preparation, administration, and disposal of hazardous drugs. It helps prevent accidental exposure, which can have serious health consequences for healthcare workers and patients.

The CSTD market has grown in response to the increasing awareness of the potential dangers associated with handling hazardous drugs and the need for stringent safety measures. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have issued guidelines and recommendations for the use of Closed System Transfer Devices to protect healthcare professionals and patients.

Closed System Transfer Devices Market Growth Factor Worldwide

The Closed System Transfer Devices (CSTD) market has witnessed substantial growth in recent years. The global demand for these advanced medical devices, designed to transfer hazardous drugs without any leakage or contamination, continues to rise rapidly. Several factors contribute to this market expansion. First and foremost, the increasing prevalence of cancer worldwide has significantly fueled the adoption of CSTDs in chemotherapy administration and drug compounding processes.

As healthcare providers prioritize patient safety and minimize the risk of exposure to harmful substances, CSTDs have emerged as a critical solution that ensures both healthcare worker protection and maximal drug efficacy. Additionally, stringent government regulations mandating the use of CSTDs further drive their market growth across various regions globally. Moreover, advancements in technology have led to more innovative CSTD designs with enhanced features such as mechanical valves and air-cleaning systems, which are highly effective at preventing hazardous drug emissions during transfer.

This continuous development propels research and development activities within the industry while fostering increased adoption rates among hospitals, clinics, ambulatory surgical centers, and pharmacies alike. Furthermore, growing awareness regarding occupational hazards associated with handling cytotoxic drugs further boosts usage rates of closed system transfer devices as a precautionary measure by care providers worldwide.

The global Closed System Transfer Devices Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

B. Braun Holding Gmbh & Co. Kg

Equashield Llc.

Fimi Opportunity Funds (Simplivia Healthcare Ltd.)

Jcb Co., Ltd. (Jms Co Ltd)

Icu Medical Inc.

Baxter International Inc

Yukon Medical, Llc.

Caragen Ltd.

Corvida Medical, Inc.

Becton, Dickinson, And Company

Browse 247 pages report Closed System Transfer Devices Market By End User (Hospitals, Oncology Centers, Pharmaceutical and Biotechnology Companies, Homecare Settings) By Drug Type (Hazardous Drugs, Non-Hazardous Drugs) By Application (Chemotherapy, Antiviral and Biological Drugs, Other Drug Classes)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030 - https://www.credenceresearch.com/report/closed-system-transfer-devices-market

The Closed System Transfer Devices (CSTD) market, which includes equipment and technologies designed to safely transfer hazardous drugs, faces several major challenges and risks:

Regulatory Compliance: CSTDs must adhere to strict regulatory guidelines and standards, such as those set forth by organizations like the U.S. Food and Drug Administration (FDA). Manufacturers and healthcare facilities must continually update and modify their devices to comply with changing regulations, which can be costly and time-consuming.

Costs: Implementing CSTDs in healthcare facilities can be expensive. The initial purchase cost, ongoing maintenance, and staff training can strain budgets. Facilities often have to weigh these costs against the potential benefits of reduced exposure risks.

Compatibility Issues: CSTDs need to be compatible with a wide range of drug containers and administration systems. Ensuring compatibility can be challenging, especially as new drugs and delivery systems are developed.

User Training: Proper training is crucial for the safe and effective use of CSTDs. Ensuring that healthcare personnel are adequately trained and consistently follow proper procedures is a challenge, as staff turnover and varying levels of experience can lead to lapses in adherence.

Product Selection: Healthcare facilities must carefully select the right CSTDs for their specific needs. With a variety of options available, including different technologies and manufacturers, making the right choice can be complex and may require extensive research.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Closed System Transfer Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Closed System Transfer Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Complete Report- https://www.credenceresearch.com/report/closed-system-transfer-devices-market

Visit our Website- https://www.credenceresearch.com

Related Reports- https://www.credenceresearch.com/report/cellulite-treatment-market

https://www.credenceresearch.com/report/cancer-biological-therapy-market

Browse Our Blog- https://www.linkedin.com/pulse/closed-system-transfer-devices-market-size-trends-analysis-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

#helathcare #medicine

0 notes

meghanester · 1 year ago

Text

Closed System Transfer Devices (CSTD) Market to Expand at a CAGR of ~15% | Driving Factors, Size, Revenue, Demand, and Opportunities During 2023-2035

Global Closed System Transfer Devices (CSTD) Market Key Insights

During the forecast period of 2023-2035, the global closed system transfer devices (CSTD) market is expected to reach an estimated value of ~USD 3500 million by 2035 by expanding at a CAGR of ~15%. The market further generated revenue of ~USD 800 million in the year 2022. Major key factors propelling the growth of the closed system transfer devices (CSTD) market are the higher utilization of closed system transfer devices to deliver antineoplastic drugs in the chemotherapy to treat the symptoms of cancer and the rising prevalence of cancer.

Market Definition of Closed System Transfer Devices (CSTD)

Closed system transfer devices (CSTD) is a system to reduce the risk of drug aerosols during the transfer of medication from one point to another. It also minimizes the risk of sharp exposure, and hazardous drug exposure and contamination. Closed-system transfer devices are used to eliminate the transfer of environmental contaminants. These devices generally come in a few design concepts that use sir-cleaning technology or physical barrier to prevent the mix of harmful drugs in the work environment.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4090

Global Closed System Transfer Devices (CSTD) Market: Growth Drivers

The growth of the global closed system transfer devices (CSTD) market can majorly be attributed to the rising prevalence of urinary tract infections and pneumonia to need the administration of antibiotics to cure the symptoms. Pneumonia is common in children and they cannot swallow antibiotics where the administration through CSTDs becomes necessary. For instance, the annual rate of death caused by pneumonia in America is estimated to be around 45000 while approximately 1 million adults suffer from it every year. On the other hand, a higher adoption rate of closed system transfer devices to avoid the side effects of chemo drugs such as, infertility, kidney and liver damage, and others are estimated to fuel the market growth during the forecast period. For instance, it was estimated that nearly 22% of acute renal infections are caused by medicinal drugs.

The global closed system transfer devices (CSTD) market is also estimated to grow majorly on account of the following:

Increasing number of chemotherapy boosting the demand for antineoplastic drugs

Rising prevalence of cancer

Growth in the adoption of closed-system transfer devices

Complexity in the oral administration of certain drugs

Technological advancement in the field of medicinal drugs

Request for customization @ https://www.researchnester.com/customized-reports-4090

Global Closed System Transfer Devices (CSTD) Market: Restraining Factor

There is a high possibility of drug leakage during the administration that can negatively impact the health of the healthcare provider. Hence this factor is expected to be the major hindrance for the growth of the global closed system transfer devices (CSTD) market during the forecast period.

Global Closed System Transfer Devices (CSTD) Market Segmentation

By Type (Membrane-to-Membrane and Needleless)

The membrane-to-membrane segment, amongst all the other segments, is anticipated to garner the largest revenue by the end of 2035. The growth of the segment can be attributed to the fact that this type has the lowest rate of risk of contamination since it also comprises a double-membrane containment system. Drug contamination can cause many types of infections such as, hepatitis C, HIV, and others. It is estimated that approximately 1.4 million new infections of hepatitis C occur every year.

By Technology (Diaphragm, Compartmentalized, Filtration, Others)

By End-User (Hospitals & Clinics, Oncology Centers, and Others)

By Region

The Asia Pacific closed system transfer devices (CSTD) market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions. The surge in the cases of cancer in the region and growing awareness of the early diagnosis of this disease leading to the high requirement of chemotherapy is estimated to expand the market size over the forecast period. It was noted in 2018, nearly 5 million deaths were accounted to cancer while 8 million new cases of cancer were diagnosed in the same year.

Obtain this Report @ https://www.researchnester.com/reports/closed-system-transfer-devices-cstd-market/4090

The market research report on global closed system transfer devices (CSTD) also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Key Market Players Featured in the Global Closed System Transfer Devices (CSTD) Market

Some of the key players of the global closed system transfer devices (CSTD) market are Becton, Dickinson and Company, B. Braun Melsungen AG, ICU Medical, Inc., Equashield, LLC, CODAN Medizinische Geräte GmbH & Co KG, Simplivia Healthcare Ltd., Corvida Medical, Inc., Caragen Ltd., Baxter International Inc., Pfizer Inc., and others.

About Research Nester

Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

#Closed System Transfer Devices (CSTD) Market

0 notes

reportprimerahul · 1 year ago

Text

Hazardous Drugs Closed System Transfer Device Market Size, Type, segmentation, growth and forecast 2023-2030

Hazardous Drugs Closed System Transfer Device Market

The Hazardous Drugs Closed System Transfer Device Market is expected to grow from USD 746.80 Million in 2022 to USD 2538.60 Million by 2030, at a CAGR of 19.10% during the forecast period.

Hazardous Drugs Closed System Transfer Device Market Size

Hazardous Drugs Closed System Transfer Devices are specialized devices that protect healthcare workers from potentially harmful exposure to hazardous drugs during drug preparation and administration. The market research report analyzes the market segments based on the type of devices, such as Closed Vial Access Devices, Closed Syringe Safety Devices, and Closed Bag/Line Access Devices, and their applications in hospitals and clinics across regions like North America, Asia Pacific, Middle East, Africa, Australia, and Europe. The major players in this market include BD Medical, Inc, Equashield, ICU Medical, Teva Medical Ltd, Corvida Medical, B. Braun, and Simplivia Healthcare Ltd. The report also includes a detailed analysis of the regulatory and legal factors specific to the market conditions. These factors play a critical role in shaping the market as they ensure compliance with industry standards and guidelines, such as USP <800>, which outlines the best practices for the handling, preparation, and administration of hazardous drugs. The report provides comprehensive insight into the Hazardous Drugs Closed System Transfer Device market trends, growth prospects, and challenges for the forecast period, 2020-2025.

Hazardous Drugs Closed System Transfer Device Market Key Player

BD Medical, Inc

Equashield

ICU Medical

Teva Medical Ltd

Corvida Medical

Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/11099

Hazardous Drugs Closed System Transfer Device Market Segment Analysis

The Hazardous Drugs Closed System Transfer Device market has been gaining popularity due to the increasing need for safety measures while handling hazardous drugs. The target market for these devices includes hospitals, clinics, pharmaceutical industries, and other healthcare facilities. The Hazardous Drugs Closed System Transfer Devices are used to transfer hazardous drugs while preventing the release of toxic substances in the environment.

One of the major factors driving the revenue growth of the Hazardous Drugs Closed System Transfer Device market is the increasing number of cancer patients globally. With the rising demand for chemotherapy treatment, the need for hazardous drug handling safety measures has increased. Also, the growing awareness about the adverse effects of exposure to hazardous drugs has led to an increase in demand for these devices.

Another major factor contributing to the growth of the Hazardous Drugs Closed System Transfer Device market is the stringent regulations implemented by governments and healthcare regulatory bodies to ensure safe handling practices for hazardous drugs. The USP <800> guidelines have played a significant role in promoting the use of Hazardous Drugs Closed System Transfer Devices.

The latest trend followed by the Hazardous Drugs Closed System Transfer Device market is the development of next-generation devices with improved safety features, ease of use, and compatibility with various drug delivery systems. Integration of RFID technology has also been observed in some devices to improve safety and traceability.

The major challenges faced by the Hazardous Drugs Closed System Transfer Device market include the high cost of the devices, lack of awareness about the safety measures, and resistance from healthcare professionals in changing their standard practices.

According to the report's main findings, the Hazardous Drugs Closed System Transfer Device market is expected to grow significantly in the coming years due to the increasing awareness about occupational hazards, the rise in the number of cancer patients, and strict regulations. The report recommends manufacturers to focus on developing cost-effective devices with advanced features to cater to the demand from various healthcare facilities.

In conclusion, the Hazardous Drugs Closed System Transfer Device market has a promising future with an increasing emphasis on safety measures while handling hazardous drugs. The market is expected to grow at a significant pace due to various factors, and the manufacturers need to focus on innovating to meet the demand from the target market.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report: https://www.reportprime.com/checkout?id=11099&price=3590

Market Segmentation (by Application):

Hospital

Clinic

Information is sourced from www.reportprime.com

#business #market growth #market strategy #market research #marketing analytics

0 notes

rohans18 · 1 year ago

Text

North America Closed System Transfer Devices Market Size, Reports, Demands, Share - Forecast 2029

Global North America Closed System Transfer Devices Market, By Type (Membrane-To Membrane Systems and Needle-Free Closed System Transfer Device), Component (Devices And Accessories), Closing Mechanism (Push-To-Turn Systems, Color-To-Color Alignment Systems, Luer-Lock System and Click-To-Lock Systems), Technology (Diaphragm-Based Devices, Compartmentalized Devices and Air Cleaning/Filtration Devices), End User (Hospitals, Oncology Centers & Clinics, Ambulatory Surgical Centers, Academic and Research Institutes), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, The Netherlands, Switzerland, Russia, Turkey, Belgium and Rest Of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest Of Asia-Pacific, Saudi Arabia, South Africa, U.A.E, Egypt, Israel, Rest Of Middle East And Africa, Brazil, Argentina and Rest Of South America) Industry Trends and Forecast to 2028.

In the consistent North America Closed System Transfer Devices market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about North America Closed System Transfer Devices industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential North America Closed System Transfer Devices market report brings precise and exact market research information that drives business into the right direction.

Key Players

Aesculap, Inc. (U.S.)

Braun Melsungen AG (Germany)

Corin Group (U.K.)

Medical Devices Business Services, Inc. (U.S.)

Smith+ Nephew (U.K.)

Stryker (U.S.)

Zimmer Biomet (U.S.)

Exactech, Inc. (U.S.)

Medacta International (U.S.)

MicroPort Orthopedics Inc. (Switzerland)

Medtronic (U.S.)

Browse More Info @ https://www.databridgemarketresearch.com/reports/north-america-closed-system-transfer-devices-market

The research studies entailed in the winning North America Closed System Transfer Devices market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the North America Closed System Transfer Devices Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

0 notes

rohit890 · 2 years ago

Text

Clinical Chemistry Analyzers Market Key Players, Share, Trends, Sales, Segmentation And Forecast To 2031

Market Overview

The global clinical chemistry analyzers market was valued at USD 12.6 billion in 2021 and it is anticipated to grow at 4.2% CAGR during the forecast period to reach up to USD 19.7 billion by 2031.

Clinical chemistry analyzers are used to calculate the concentration of certain electrolytes, metabolites, and drugs in serum, cerebrospinal fluid, and other body fluids among others. It creates an accurate result within the lease period and is planned for extremely advanced technology. It is used to validate health conditions like nutritional status, liver functions, and kidney functions among others. Different types of tests such as lipid profile, liver panel, and a renal panel comprising therapeutic drugs are used to enhance metabolic functions. Rising demand for clinical tests and the increasing prevalence of endocrine diseases are the major factors driving the growth of the market.

View Detailed Report Description: https://www.globalinsightservices.com/reports/closed-system-transfer-devices-market/

Market Dynamics

The key factor propelling the growth of the market is the rising geriatric population coupled with the increasing prevalence of chronic and lifestyle diseases. The increasing geriatric population in developed and developing regions will positively influence the growth of the clinical chemistry analyzers market. Owing to rapid growth in the elderly population, the prevalence of age-associated diseases like hypertension, diabetes, cardiovascular, liver, and kidney diseases are anticipated to increase significantly. The diagnosis and management of such diseases are responsible for the rising number of prescriptions for tests like basic metabolic panel, lipid profile, and liver & renal panel. The growth in chronic illnesses will increase the demand for tests prescribed for the prevention, diagnosis, and treatment of the same. These factors, alongside the growing trend for preventive medicine, is expected to drive the demand for clinical chemistry analyzers during the projection period. These tests are performed by clinical chemistry analyzers; so, it is expected to have a positive impact on this market.

The major factor hindering the growth of the market is the requirement of high capital investment and a shortage of skilled laboratory technicians. The high-volume clinical chemistry analyzers may be affordable only for large hospitals and reference laboratories with high capital budgets. Most small laboratories, physician’s offices, and sole practitioners have no capital budgets and may not be able to afford a large or very large-sized analyzer. So, the high fixed-cost requirements limit the growth of the clinical chemistry analyzers market.

Get Free Sample Copy of This Report: https://www.globalinsightservices.com/request-sample/GIS10255

The key players in the global clinical chemistry analyzers market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), HITACHI (Japan), EKF Diagnostics (UK), Ortho Clinical Diagnostics (US), ELITech Group (France), Mindray Medical International Ltd. (China), BIOBASE Group (China), SFRI Medical Diagnostics (France), Trivitron Healthcare Pvt. Ltd. (India), Randox Laboratories Ltd. (UK), Medica Corporation (US), Meril Life Sciences Pvt. Ltd. (India), Erba Mannheim (UK), Genrui Biotech Inc. (China), DIRUI Industrial Co. Ltd. (China), Teco Diagnostics (US), Balio Diagnostics (France), Snibe Co. Ltd. (China), and AMS Alliance (Italy).

About Global Insight Services:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: [email protected]

Phone: +1–833–761–1700

0 notes

article-research · 3 years ago

Text

Closed System Drug Transfer Device Market Size, Share, Growth Opportunity and Trends by Growing CAGR Till 2026

The global Closed System Drug Transfer Device Market report offers a comprehensive assessment of the market for the forecast years. The report contains several segments and an analysis of the market trends and growth factors that are playing a vital role in the market. These factors encompass the drivers, restraints, and opportunities. This globe industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.

The key market players for the global Closed System Drug Transfer Device market are listed below:

BD Medical, Inc

Teva Medical Ltd

Equashield

ICU Medical

B. Braun

Corvida Medical

Others

Click here to get a FREE Sample Copy of the Closed System Drug Transfer Device Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-24308

The Global Closed System Drug Transfer Device Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risk factors. The report is bifurcated by top global manufactures mentioning sales, revenue, and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.

COVID-19 Impact Analysis on Closed System Drug Transfer Device Market

The global pandemic COVID-19 has affected the Closed System Drug Transfer Device (CSTD) market directly or indirectly. This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic. The detailed study highlights the probable outcomes of this global crisis on the Closed System Drug Transfer Device (CSTD) industry. The impact study on production, supply-demand, and sales provides a holistic approach to the future.

Do You Have Any Query Or Report Customization? Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-24308

Why Purchase this Report?

A robust research methodology has been followed to collect data for the report. Data, thus collected passes through multiple quality checks to ensure the best quality is served.

The report gives a holistic view of the competitive scenario of the Closed System Drug Transfer Device (CSTD) market

The latest product launches along with technological changes and development are covered in the report.

The data analysis in the report helps in understanding the anticipated Closed System Drug Transfer Device (CSTD) market dynamics from 2021 to 2026.

DecisionDatabases has a vast repository of data, therefore, we can accommodate customized requirements also.

The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.

The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.

To better understand the market scenario, the Closed System Drug Transfer Device (CSTD) market is segmented as below:

By Types:

Closed Vial Access Devices

Closed Syringe Safety Devices

Closed Bag/Line Access Devices

By Applications:

Hospital

Clinic

By Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

The Middle East and Africa (Turkey, GCC, Rest of Middle East)

The content of the study subjects includes a total of 14 chapters:

Chapter 1: To describe Closed System Drug Transfer Device (CSTD) product scope, market overview, market opportunities, market driving force, and market risks. Chapter 2: To profile the top manufacturers of Closed System Drug Transfer Device (CSTD), with price, sales, revenue, and global market share of Closed System Drug Transfer Device (CSTD) in 2018 and 2019. Chapter 3: The Closed System Drug Transfer Device (CSTD) competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4: The Closed System Drug Transfer Device (CSTD) breakdown data are shown at the regional level, to show the sales, revenue, and growth by region, from 2015 to 2020. Chapter 5 and 6: To segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020. Chapter 7, 8, 9, 10 & 11: To break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2016 to 2021 and Closed System Drug Transfer Device market forecast, by regions, type, and application, with sales and revenue, from 2021 to 2026. Chapter 12, 13 & 14: To describe Closed System Drug Transfer Device (CSTD) sales channel, distributors, customers, research findings and conclusion, appendix, and data source.

Directly Purchase the Complete Global Closed System Drug Transfer Device Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-24308

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

Referral Source - https://view.publitas.com/decisiondatabases-com-_vzxge7jabyb/closed-system-drug-transfer-device-market-research-report-from-2021-to-2026/

#Closed System Drug Transfer Device Market #Closed System Drug Transfer Device Market Size #Closed System Drug Transfer Device Market Growth #Closed System Drug Transfer Device Market Trends #Global Closed System Drug Transfer Device Industry Report #Closed System Drug Transfer Device Market Analysis #COVID-19 Outbreak on Closed System Drug Transfer Device Market #Closed System Drug Transfer Device Market Demand

0 notes

diarrheaworldstarhiphop · 6 years ago

Photo

Hodeidah, Yemen (CNN) – Saudi Arabia and its coalition partners have transferred American-made weapons to al Qaeda-linked fighters, hardline Salafi militias, and other factions waging war in Yemen, in violation of their agreements with the United States, a CNN investigation has found.

The weapons have also made their way into the hands of Iranian-backed rebels battling the coalition for control of the country, exposing some of America's sensitive military technology to Tehran and potentially endangering the lives of US troops in other conflict zones.

Saudi Arabia and the United Arab Emirates, its main partner in the war, have used the US-manufactured weapons as a form of currency to buy the loyalties of militias or tribes, bolster chosen armed actors, and influence the complex political landscape, according to local commanders on the ground and analysts who spoke to CNN.

By handing off this military equipment to third parties, the Saudi-led coalition is breaking the terms of its arms sales with the US, according to the Department of Defense. After CNN presented its findings, a US defense official confirmed there was an ongoing investigation into the issue.

The revelations raise fresh questions about whether the US has lost control over a key ally presiding over one of the most horrific wars of the past decade, and whether Saudi Arabia is responsible enough to be allowed to continue buying the sophisticated arms and fighting hardware. Previous CNN investigations established that US-made weapons were used in a series of deadly Saudi coalition attacks that killed dozens of civilians, many of them children.

The developments also come as Congress, outraged with Riyadh over the murder of journalist Jamal Khashoggi last year, considers whether to force an end to the Trump administration's support for the Saudi coalition, which relies on American weapons to conduct its war.

In 2015, Riyadh launched a coalition to oust Iranian-supported Houthi rebels from the country's capital and reinstate the internationally recognized government of President Abdu Rabu Mansour Hadi. The war split the country in two, and with it came the weapons -- not just guns, but anti-tank missiles, armored vehicles, heat-seeking lasers and artillery -- all flooding into an unruly and complex state.

Since then, some of America's "beautiful military equipment," as US President Donald Trump once called it, has been passed on, sold, stolen or abandoned in Yemen's state of chaos, where murky alliances and fractured politics mean little hope for any system of accountability or tracking.

Some terror groups have gained from the influx of US arms, with the barrier of entry to advanced weaponry now lowered by the laws of supply and demand. Militia leaders have had ample opportunity to obtain military hardware in exchange for the manpower to fight the Houthi militias. Arms dealers have flourished, with traders offering to buy or sell anything, from a US-manufactured rifle to a tank, to the highest bidder.

And Iran's proxies have captured American weapons they can exploit for vulnerabilities or reverse-engineer for native production.

'Do you have American guns here?'

In the narrow, ramshackle streets of Taiz's historic district, weapons shops lie tucked between women's clothing stores.

Arms markets are illegal in Yemen, but that doesn't stop them operating openly in this large, mountainous city in the country's southwest.

To one side hang veils, abayas and colorful dresses for sale; to the other are pistols, hand grenades, and US assault rifles available on special order.

In one arms market, sweets were displayed among the ammunition. "Do you have American guns here?" CNN asked. "The American guns are expensive and sought after," the weapons trader replied, in an exchange captured by undercover CNN cameras.

In another of the city's markets, a very young-looking boy handled weapons like an expert. Men joked and chewed khat, a commonly used drug, and the atmosphere was casual. But these shops don't just take individual orders, they can supply militias -- and it's this not-so-hidden black market that in part is driving the demand for hi-tech American weapons and perpetuating the cycle of violence in Yemen.

Once the intellectual heart of the country, Taiz is now a tinder box that set off a war within a war last year, when the various militias backed by the Saudi-led coalition turned their guns on each other.

Amid the chaos of the broader war, al Qaeda in the Arabian Peninsula (AQAP) made its way to the frontlines in Taiz in 2015, forging advantageous alliances with the pro-Saudi militias they fought alongside.

One of those militias linked to AQAP, the Abu Abbas brigade, now possesses US-made Oshkosh armored vehicles, paraded in a 2015 show of force through the city.

Abu Abbas, the founder, was declared a terrorist by the US in 2017, but the group still enjoys support from the Saudi coalition and was absorbed into the coalition-supported 35th Brigade of the Yemeni army.

“Oshkosh Defense strictly follows all US laws and regulations relating to export control," the firm told CNN.

And there are deadlier forms of weaponry that have made their way into the city. In October 2015, military forces loyal to the government boasted on Saudi- and UAE-backed media that the Saudis had airdropped American-made TOW anti-tank missiles on the same frontline where AQAP had been known to operate at the time.

Local officials confirmed that the airdrop happened, but CNN's attempts to conduct further interviews were blocked and the team was intimidated by the local government. A local activist joked that the weapons had probably been sold on.

Graveyard of US military hardware

At a graveyard of discarded US-made military hardware near the flashpoint port city of Hodeidah, it becomes clear that the Alwiyat al Amalqa -- the Giants Brigade, a predominantly Salafi, or ultra-conservative Sunni, militia -- is a favored faction.

Nearly half a dozen Mine-Resistant Ambush Protected (MRAP) vehicles sit side by side, most bearing stickers with the insignia of the Giants Brigade.

One even has the export label on it showing it was sent from Beaumont, Texas to Abu Dhabi, in the UAE, before ending up in the hands of the militia. The serial number of another MRAP reveals it was manufactured by Navistar, the largest provider of armored vehicles for the US military.

The armored all-terrain vehicles are built to withstand ballistic arms fire, mine blasts and improvised explosive devices (IEDs). “It’s the vehicle that every crew wants when they’re out in the field,” Navistar’s website says. The firm declined to comment on this report.

Recipients of US weaponry are legally obligated to adhere to end-use requirements which prohibit the transferring of any equipment to third parties without prior authorization from the US government. That authorization was never obtained.

The Saudi coalition did not respond to multiple requests for comment. A senior UAE official denied “in no uncertain terms that we are in violation of end-user agreements in any manner.”

The Giants Brigade is a “part of Yemeni forces,” the official told CNN, adding that the group was under the direct supervision of the UAE and, therefore, the equipment was in the “collective possession” of the coalition.

The US Department of Defense, when asked specifically about the Giants Brigades, said it had not given Saudi Arabia or the UAE permission to hand over US weaponry to other factions on the ground.

"The United States has not authorized the Kingdom of Saudi Arabia or the United Arab Emirates to re-transfer any equipment to parties inside Yemen," Pentagon spokesman Johnny Michael told CNN. "The US government cannot comment on any pending investigations of claims of end-use violations of defense articles and services transferred to our allies and partners."

Iran is ‘assessing US military technology closely’

Because a majority of American troop deaths in Afghanistan and Iraq are caused by IEDs, it is critical that knowledge of MRAP vulnerabilities does not fall into enemy hands.

But it's already too late.

In September 2017, a Houthi-run TV channel broadcast images of Mohammed Ali al-Houthi, the de facto rebel leader, proudly sitting behind the wheel of a captured US-made MRAP in the capital Sanaa, as a crowd chanted "death to America" in the background.

CNN obtained an image showing the serial numbers of a second American MRAP in the hands of another senior Houthi official last year in Hodeidah.

The vehicle was part of a $2.5 billion sale to the UAE in 2014. The sale document, seen by CNN, certifies that "a determination has been made that the recipient country can provide the same degree of protection for the sensitive technology" as the United States.

MRAPs like these, captured on the battlefield, have been probed by Iranian intelligence, according to a member of a secret Houthi unit backed by Iran known as the Preventative Security Force. The unit oversees the transfer of military technology to and from Tehran.

The member of the force, speaking to CNN anonymously out of fear for his safety, revealed that Iranian and Hezbollah advisers have already gotten their hands on the armored vehicles and other US military hardware.

"Iranian intelligence are assessing US military technology very closely," the source said in an audio interview done from Sanaa. "Listen, there isn't a single American weapon that they don't try to find out its details, what it's made of, how it works."

IEDs are now mass-produced in Yemen by Houthi forces on a scale only previously achieved by ISIS, according to a report published by Conflict Armament Research.

The group tracks weapons and their supply chains in conflict zones, and has found IEDs containing Iranian components in Yemen.

Hiram Al Assad, a member of the Houthi Political Council, confirmed to CNN that the MRAPs were still in Houthi hands but denied the existence of the Preventative Security Force.

Iran has not responded to a CNN request for comment.

Human cost of conflict

The flood of US weaponry is fueling a conflict that has killed tens of thousands -- among them children on school buses and families fleeing violence -- and pushed millions more to the brink of famine.

Two-year-old Rehab is so severely malnourished that her chest has collapsed into a deep dent at the center of her tiny body.

There are an estimated 200 cases of malnutrition like hers in the village of Tohta, a frontline area surrounded by artillery and mortar positions on the Red Sea coast near Hodeidah.

A few months ago, the local clinic was shut down due to political disagreements over funding. But Dr. Fatma Ibrahim won’t give up.

She conducts house-to-house visits every week, and as soon as she steps into the street, worried parents flock to her.

“Look, look,” one father demands as he shows the doctor his skeletal 14-month-old girl, Roula. Ibrahim gently examines her, but soon it's time to move on to the next baby.

For a young man, joining a fighting faction is one of the few means of finding employment in a poor country with little infrastructure and a barely functioning economy.

At the same time, too many powerful political figures and key armed actors in the region have been prospering greatly from the conflict and, as a result, they lack the incentives to agree to a peace process that would threaten their financial gain.

The US is by far the biggest supplier of arms to both Saudi Arabia and the United Arab Emirates, and its support is crucial to the Saudi-led coalition’s continuing war in Yemen.

US lawmakers are trying to pass a resolution ending the Trump administration’s support for the coalition. But there is scant evidence that the White House wants to listen, despite evidence that the actions of a key US ally may be making Americans less safe.

In the wake of the murder of Jamal Khashoggi murder last year, Trump said it would be foolish for the US to cancel multi-billion dollar arms deals with the Saudis. "I don't want to lose all of that investment being made into our country," he said.

#yemen #united states #obama administration #Trump Administration #USA #houthis #yemeni civil war

9 notes · View notes

mrfrblogresearch02 · 3 years ago

Text

Closed System Drug Transfer Device Market is Staring at a Promising Future Owing to High Demand for 2022 – 2027

Market Overview: The global closed system drug transfer device (CSTD) market Trends size is poised to expand at 19.10% CAGR over the forecast period. The closed system drug transfer device (CSTD) market is growing rapidly over recent years. Factors such as the rising prevalence of cancer and the need to protect healthcare workers and biotechnology scientists & assistants against the harmful risks of hazardous drug exposure are driving the growth of the market. Besides, guidelines outlined by federal agencies such as the National Institute for Occupational Safety and Health (NIOSH) to prevent possible workplace hazards are spurring the CSTD market demand. Furthermore, the growing uses of biologics and substantial investments drawn in the R&D to develop advanced CSTDs are boosting the growth of the market significantly. Additionally, spreading awareness, advantages of CSTD, and beneficial reimbursement policies impact the market growth, positively. Segmentation Analysis: The market is segmented into four dynamics to widen the scope of understanding,

By Type: Barrier-Type and Filtration-Type.

By Delivery: Closed Vial Access Devices, Closed Bag/Line Access Devices, and Closed Syringe Safety Devices.

By End-user: Specialty Centers, Hospitals & Clinics, and others.

By Regions: Europe, North America, APAC, and the Rest-of-the-World (RoW). Regional Analysis: North America dominates the global closed system transfer device brands with the largest market share. Major factors that are driving the regional market growth include the rise in cancer cases and funding support to encourage research and development infrastructure. Additionally, well-spread awareness of CSTD alongside technological advances in the healthcare industry boosts the growth of the regional market.

A huge patient pool undergoing treatments for cancer and the increasing geriatric population in the region support the growth of the market. Moreover, surging numbers of research activities and comparatively higher adoption of related CSTDs in the US and Canada impact the regional market growth, positively. Furthermore, the presence of major market players and developed healthcare infrastructure foster regional market growth.

Europe is another phenomenally growing market closed system drug transfer device, globally. Flourishing medical device markets, burgeoning life science industries, and the presence of pharma giant companies bolster the regional market growth.

The resurging economy in Europe plays a vital role in market development, allowing the proliferation of the healthcare sector in the region. Furthermore, increasing investment in the development of CSTDs drives the regional market on a large scale. The European CSTD market is estimated to register a phenomenal CAGR during the review period.

Closed System Drug Transfer Device market in the Asia Pacific region is growing rapidly. This growth attributes to the investments by new players and the increasing prevalence of cancer. Besides, government initiatives to encourage safe drug handling practices in India and China are influencing regional market growth. Furthermore, the growing demand for quality devices in biotechnology and rapidly developing healthcare technology is expected to lead the market growth in the APAC region. Competitive Analysis: Key players in the closed system drug transfer device (CSTD) market include Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.), Corvida Medical (U.S.), ICU Medical Inc. (U.S.), Yukon Medical (U.S.), and Equashield LLC (U.S.).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

#Closed System Drug Transfer Device Market

0 notes

healthcare-market · 3 years ago

Text

Poultry Health Market to Flourish with an Impressive CAGR by 2025

The poultry health market is set to see growth at an impressive CAGR (Compound Annual Growth Rate) of 7.6% between 2017 and 2025, owing to increasing levels of awareness regarding poultry diseases, owing to a recent study by Transparency Market Research. This will pull up the market share to a hefty USD 11 bn by the end of the forecast period; it is a steep rise from USD 5.7 bn in 2016.

Request a Sample of Poultry Health Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35876

Global Poultry Health Market’s Competitive Landscape to be Consolidated over the Forecast Period

The market is slightly consolidated and highly competitive. Players are focusing their energy on figuring the optimum marketing strategy. Besides, to maintain an edge over competitors in the market, players invest substantially in research and development. It helps players adapt to changing needs and stay at the vanguard of their innovation game. Prominent players in the market landscape are Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health, Merck, Merial (Animal Division Of Sanofi), Virbac, Zoetis Animal Healthcare, among others. Mergers and acquisitions also play a critical role in the global poultry health market landscape.

In June 2018, Bayer acquired Monsanto and in the May of the same year, Boehringer Ingelhein, pumped in more investment in China through its Asia Veterinary Research and Development Center (Research and Development). The aim of expanding it is to ensure better research and development in the market.

Enquiry Before Buying Poultry Health Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=35876

North America to Hold the Lion’s Share of the Market Growth over the Forecast Period

Owing to a large consumption of mean and a shift towards white meat from red meat, North America will hold a large chunk of the market share, revenue wise. Besides, as more people move towards an active lifestyle in the region, after a long duration if rising incidence of obesity, there is demand for protein rich food, leading to demand for eggs and meat. Technological advancements in the field, owing to a number of prominent players existing in the region are also leading to growth in the region.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35876

One of the other regions that will chart significant growth is the Asia Pacific (APAC) where a number of governments are participating in improving health of poultry animals owing to pressure from animal welfare organization and the endeavor to promote sustainable development of livestock. For, instance, National Livestock Mission program in India is a perfect case in point. This is set to create new untapped opportunities for market to witness growth. Besides, in this region, since poultry provide incomes and nutritional security, it holds a prominent place in the scheme of government promotions.

Request for Analysis of COVID19 Impact on Poultry Health Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=35876

As per a recent study by International Food Policy Research Institute, it is believed that developing nations will be producing 40% additional meat and 60% additional milk by 2020. Base year here was 1990.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html

https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html

https://www.prnewswire.co.uk/news-releases/closed-system-transfer-devices-market-to-observe-notable-growth-due-to-increase-in-use-of-oncology-drugs-and-emergence-of-novel-protocols-in-pharmaceutical-industry-says-tmr-825812545.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]

Website: https://www.transparencymarketresearch.com/

0 notes